August 25, 2016 12:53 AM ET

Biotechnology

Company Overview of Diacrin, Inc.

Company Overview

As of August 21, 2003, Diacrin, Inc. was acquired by GenVec, Inc. Previously, Diacrin, Inc. focused on developing cell transplantation technology for treating human diseases that were characterized by cell dysfunction or cell death, and for which current therapies were either inadequate or nonexistent. The company was founded in 1989 and had principal executive offices in Charlestown, Massachusetts.

Building 96 13th Street

Charlestown Navy Yard

Charlestown, MA 02129

United States

29 Employees

Phone:

617-242-9100

Fax:

617-242-0070

Key Executives for Diacrin, Inc.

Diacrin, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Diacrin, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.